...
首页> 外文期刊>Neurogastroenterology and motility >Temporary self-expanding cardia stents for the treatment of achalasia: an experimental study in dogs.
【24h】

Temporary self-expanding cardia stents for the treatment of achalasia: an experimental study in dogs.

机译:用于门失弛缓症的临时自扩张card门支架:在狗中进行的实验研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: To assess the performance, efficiency and optimal removal time of a newly designed temporary retrievable cardia covered stent (TRC-CS) for the treatment of achalasia in a dog model. METHODS: Eighty-four achalasia-like dog models were randomly divided into seven groups of 12, a control group (CG; no stent insertion), a standard stent control group (NSCG, standard esophageal stent) and five treatment groups (TG, TRC-CS). Stents were retrieved at 4 days after insertion in the NSCG and at 4 days(4 d-TG), 2 weeks(2 w-TG), 1 month(1 m-TG), 3 months(3 m-TG), and 6 months(6 m-TG) in the TGs. Lower esophageal sphincter pressure (LESP) and a timed barium esophagram were assessed before stent insertion, after stent retrieval, and at 1-week, 1-, 3- and 6-month follow-up. Three dogs in NSCG and 4 d-TG were sacrificed for histological examination at each follow-up to investigate the inflammatory reaction after stent insertion. KEY RESULTS: Stent insertion/removal and the follow-up procedures were well tolerated. At 6-month follow-up, the 2 w-TG and 1 m-TG demonstrated an acceptable stent migration (n = 2 in both TGs vs n = 4 in NSCG, n = 4 in 3 m-TG, and n = 6 in 6 m-TG), improved LESP compared to after benzyl-dimethyltetradecylammonium chloride (BAC) injection (P < 0.05), and improved timed barium height (P = 0.0144 and 0.0409). Mouse -proliferating cell nuclear antigen (PCNA) and alpha-smooth muscle actin staining revealed no inflammatory reaction difference between the NSCG and 4 d-TG at each follow-up. CONCLUSIONS & INFERENCES: The TRC-CS was effective in the treatment of achalasia in a dog model. LESP measurements, timed barium esophagram studies suggest an optimal stent retrieval time of between 2 w approximately 1 m.
机译:背景:为了评估在狗模型中治疗designed门失弛缓症的一种新设计的临时可回收心脏覆盖支架(TRC-CS)的性能,效率和最佳去除时间。方法:将84只门失弛症样犬随机分为7组,每组12只,对照组(CG;无支架插入),标准支架对照组(NSCG,标准食管​​支架)和5个治疗组(TG,TRC) -CS)。插入NSCG后第4天和第4天(4 d-TG),2周(2 w-TG),1个月(1 m-TG),3个月(3 m-TG)和TG中6个月(6 m-TG)。在支架置入前,支架置入后以及在1周,1、3和6个月的随访中评估了较低的食道括约肌压力(LESP)和定时钡食道造影。每次随访时处死三只NSCG狗和4 d-TG,以进行组织学检查,以调查支架置入后的炎症反应。关键结果:良好的耐受性支架插入/移除和后续程序。在6个月的随访中,2 w-TG和1 m-TG表现出可接受的支架迁移(两个TG中n = 2,NSCG中n = 4,3 m-TG中n = 4,n = 6在6 m-TG中,与注射苄基二甲基十四烷基氯化铵(BAC)后相比,LESP改善(P <0.05),定时钡高度得到改善(P = 0.0144和0.0409)。小鼠增殖细胞核抗原(PCNA)和α平滑肌肌动蛋白染色显示,每次随访时,NSCG和4 d-TG之间没有炎症反应差异。结论与推论:TRC-CS可有效治疗狗模型中的门失弛缓症。 LESP测量,定时钡盐食管造影术研究表明,最佳支架收回时间介于2 w到大约1 m之间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号